About
This program delves into the fascinating and evolving field of viral oncology. Through a combination of lectures, discussions, and case studies, participants will gain a deeper understanding of how viruses can hijack cellular processes and contribute to cancer initiation and progression.
Aim
To empower participants with a comprehensive understanding of cancer viruses, their role in tumorigenesis, and the emerging strategies for therapeutic intervention.
Program Objectives
- Explore the diverse range of viruses implicated in human cancers.
- Analyze the mechanisms by which viruses contribute to cancer development.
- Discuss the current methods for diagnosing and monitoring viral-associated cancers.
- Evaluate the potential of antiviral therapies and vaccines in cancer prevention and treatment.
- Explore the burgeoning field of oncolytic virotherapy and its applications.
- Identify the ethical considerations surrounding the use of viruses in cancer therapy.
Program Structure
Module 1: Introduction to Viral Oncology
Week 1: Understanding Cancer Viruses
Overview of the history of viral oncology and its significance.
Introduction to oncogenic viruses and their role in cancer development.
Basic concepts of viral oncology, including key terminology and mechanisms.
Week 2: Key Concepts in Virology and Oncology
Detailed exploration of virus biology and cancer cell interactions.
Study of how viral mechanisms contribute to cancer cell transformation.
Examination of fundamental concepts in virology and oncology through interactive diagrams.
Module 2: Major Oncogenic Viruses
Week 3: Human Papillomavirus (HPV) and Cervical Cancer
Pathogenesis of HPV and its link to cervical cancer development.
Review of global health impacts and success stories of the HPV vaccine.
Analysis of screening data to understand trends and effectiveness of HPV prevention strategies.
Week 4: Hepatitis B and C Viruses and Liver Cancer
Overview of hepatocellular carcinoma and its association with hepatitis B and C viruses.
Simulation activities on liver cancer progression and viral interaction dynamics.
Study of hepatitis viruses’ epidemiology and their role in liver cancer.
Week 5: Epstein-Barr Virus (EBV) and Associated Cancers
Examination of EBV and its relationship with lymphomas and other cancers.
Discussion on current research and developments regarding EBV vaccines.
Case studies on EBV, focusing on clinical presentations and epidemiology.
Participant’s Eligibility
- Biotech, Pharma, and Life Sciences graduates
- Post-graduates specializing in virology, oncology, or immunology
- Academicians researching cancer viruses
- Industry professionals seeking to advance their knowledge in viral oncology
- Anyone interested in the role of viruses in cancer development
Program Outcomes
- Acquire a critical understanding of the link between viruses and cancer.
- Gain insights into the latest diagnostic and therapeutic strategies for viral-associated cancers.
- Identify potential career paths within the field of viral oncology research.
- Stay informed about the cutting-edge advancements in oncolytic virotherapy.
Program Deliverables
- Access to e-LMS
- Real-Time Project for Dissertation
- Project Guidance
- Paper Publication Opportunity
- Self Assessment
- Final Examination
- e-Certification
- e-Marksheet